SRC家族激酶抑制剂NXP900在状细胞癌中表现出强大的抗瘤活性
Sweta Dash1, Sabrina Hanson1, Ben King2
1Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute at Frederick, NIH, Frederick, Maryland, USA.
The Journal of biological chemistry
|August 1, 2024
概括
NXP900是一种新型的SRC家族激酶 (SFK) 抑制剂,通过将SRC锁定在不活跃状态中,有效地向癌细胞. 这种独特的机制在治疗特定的头和食道癌症方面表现有前途.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 通过催化和非催化功能,SRC家族激酶 (SFKs) 在瘤发生中发挥着至关重要的作用.
- 针对SRC的现有的多位激酶抑制剂与活性构造结合,允许产生前瘤性支架功能.
- NXP900代表了一类新的抑制剂,通过稳定不活跃的"封闭"形状来向SFKs.
研究的目的:
- 在癌症的临床前模型中研究选择性SFK抑制剂NXP900的疗效.
- 将NXP900的作用机制与现有的多向激酶抑制剂进行比较.
- 为了确定可能从NXP900治疗中受益的特定癌症类型和患者群体.
主要方法:
- 描述NXP900的结合机制和标选择性.
- 评估NXP900在食道状细胞癌和头状细胞癌细胞系中的抗癌活性.
- 在体内使用相关的临床前癌症模型评估NXP900的疗效.
主要成果:
- NXP900对SFK成员表现出亚纳米分子活性,具有很高的标选择性.
- 食道状细胞癌和头状细胞癌在体外和体内都对NXP900表现出极高的敏感性.
- NXP900有效地抑制了SRC的酶依赖和酶独立的功能.
结论:
- NXP900独特的锁定SRC在封闭形状的机制提供了强大的和特定的SFK路径抑制.
- NXP900对食道和头角状细胞癌具有显著的治疗潜力.
- 确定可能对NXP900治疗有反应的患者群体需要进一步的临床研究.
更多相关视频
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.2K
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
11.0K
相关概念视频
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
157
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
157